109 related articles for article (PubMed ID: 19700027)
1. Lymphomatoid papulosis while on efalizumab.
Leo AM; Ermolovich T
J Am Acad Dermatol; 2009 Sep; 61(3):540-1. PubMed ID: 19700027
[No Abstract] [Full Text] [Related]
2. Efalizumab-induced thrombocytopenia: report of relapse after re-administration.
Kiorpelidou D; Tsiouri G; Gaitanis G; Akritidis N; Bassukas ID
Clin Exp Dermatol; 2009 Dec; 34(8):e914-6. PubMed ID: 20055866
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum responding to ciclosporin without adverse effects in a patient with lymphomatoid papulosis.
Busick TL; Bennett DD; Cohen JB
Clin Exp Dermatol; 2010 Dec; 35(8):918-9. PubMed ID: 20456406
[No Abstract] [Full Text] [Related]
4. Lymphomatoid papulosis and FK 506.
Siddiqui MA; Sullivan S; al-Mofadhi AM
Int J Dermatol; 1997 Mar; 36(3):202-5. PubMed ID: 9159004
[No Abstract] [Full Text] [Related]
5. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Samaraweera AP; Cohen SN; Akay EM; Evangelou N
Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
[TBL] [Abstract][Full Text] [Related]
6. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
de Groot M; de Rie MA; Bos JD
Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
[No Abstract] [Full Text] [Related]
7. Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
Laube S; Stephens M; Smith AG; Whittaker SJ; Tan BB
Br J Dermatol; 2005 Jun; 152(6):1346-8. PubMed ID: 15949007
[TBL] [Abstract][Full Text] [Related]
8. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.
Antonucci A; Bardazzi F; Balestri R; Patrizi A
J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361
[TBL] [Abstract][Full Text] [Related]
9. Verapamil and lymphomatoid papulosis in chronic cluster headache.
Afridi S; Bacon CM; Bowling J; Goadsby PJ
J Neurol; 2004 Apr; 251(4):473-5. PubMed ID: 15083295
[No Abstract] [Full Text] [Related]
10. Cytomegalovirus infection in a patient treated with efalizumab for psoriasis.
Miquel FJ; Colomina J; Maríi JI; Ortega C
Arch Dermatol; 2009 Aug; 145(8):961-2. PubMed ID: 19687445
[No Abstract] [Full Text] [Related]
11. CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma?
Haus G; Utikal J; Geraud C; Goerdt S; Leverkus M
Br J Dermatol; 2014 Sep; 171(3):668-70. PubMed ID: 24689991
[No Abstract] [Full Text] [Related]
12. Severe erythroderma in a patient under intermittent therapy with efalizumab.
Hernandez Garcia I
J Drugs Dermatol; 2008 Oct; 7(10):987-9. PubMed ID: 19112767
[TBL] [Abstract][Full Text] [Related]
13. Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy.
Weisenseel P; Kuznetsov AV; Flaig M; Prinz JC
Dermatology; 2008; 217(1):85-6. PubMed ID: 18446030
[TBL] [Abstract][Full Text] [Related]
14. Efalizumab treatment associated with Candida colitis.
Kitagawa KH; Kalb RE
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S120-1. PubMed ID: 19119121
[No Abstract] [Full Text] [Related]
15. A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasis.
Caproni M; Volpi W; Chiarini C; Antiga E; Giomi B; Fabbri P
Br J Dermatol; 2009 Apr; 160(4):896-7. PubMed ID: 19239461
[No Abstract] [Full Text] [Related]
16. Case reports: efalizumab-associated lymphoproliferative disease.
Bommakanti S; Patil A; Eshoa C; Chitambar CR
J Drugs Dermatol; 2007 Jun; 6(6):646-8. PubMed ID: 17668531
[TBL] [Abstract][Full Text] [Related]
17. Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris.
Ohtsuka T
J Dermatol; 2014 Apr; 41(4):354-5. PubMed ID: 24617533
[No Abstract] [Full Text] [Related]
18. Urticarial vasculitis due do infliximab.
Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
[No Abstract] [Full Text] [Related]
19. Cutaneous adverse effects of biological therapies for psoriasis.
Roé E; Puig L; Corella F; García-Navarro X; Alomar A
Eur J Dermatol; 2008; 18(6):693-9. PubMed ID: 18955203
[TBL] [Abstract][Full Text] [Related]
20. Lymphomatoid drug reaction to ustekinumab.
Jung J; Levin EC; Jarrett R; Lu D; Mann C
Arch Dermatol; 2011 Aug; 147(8):992-3. PubMed ID: 21844471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
